Skip to main content

Table 3 Perioperative outcomes

From: Total arterial revascularization in patients with acute myocardial infarction – feasibility and outcomes

Parameter SV group *
n = 152
TAR group *
n = 98
p-value
Transfusions
 Erythrocytes
  Rate 116 (76) 56 (57) < 0.001
  Amount (units)** 2 ± 2.6 1 ± 2.7 0.041
 Platelets
  Rate 56 (37) 35 (36) 0.86
  Amount (units)** 0 ± 1.0 0 ± 0.90 0.33
 Fresh frozen plasma
  Rate 45 (30) 22 (22) 0.21
  Amount (units)** 0 ± 2.0 0 ± 2.0 0.46
Re-thoracotomy for bleeding 9 (5.9) 3 (3.1) 0.30
Sternal wound healing impairment requiring surgical revision 4 (2.6) 4 (4.0) 0.52
 Superficial 2 (1.3) 3 (3.0)
 Deep 2 (1.3) 1 (1.0)
Duration of invasive ventilation (hours)** 14 ± 58 10 ± 73 0.61
Postoperative tracheostomy 11 (7.2) 5 (5.1) 0.30
New onset atrial fibrillation 29 (19) 10 (10) 0.059
Stroke (>Rankin1) 3 (2.0) 0 0.1
Acute kidney injury
KDIGO I 59 (40) 32 (33) 0.17
KDIGO II 11 (7.5) 4 (4.1)
KDIGO III 6 (3.9) 5 (5.1)
Postoperative dialysis 6 (3.9) 5 (5.1) 0.69
Postoperative length of ICU stay (hours)** 73 ± 81 46 ± 93 0.28
Postoperative length of hospital stay (days) ** 10 ± 4.5 10 ± 3.4 0.58
30-day all-cause mortality 6 (4.5) 3 (3.4) 0.68
  1. Abbreviations: ECLS extracorporeal life support, KDIGO Kidney disease: improving global outcomes, SV saphenous vein grafts, TAR total arterial revascularization
  2. aContinuous variables: mean ± SD; categorical variables: n (%)
  3. bMedian ± SD